Cargando…
P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
Autores principales: | Elenga, N., Etienne-Julan, M., Loko, G., AlOkka, R., Adel, A., Yassin, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431337/ http://dx.doi.org/10.1097/01.HS9.0000848868.53553.7f |
Ejemplares similares
-
P115: REAL-WORLD DATA ON THE EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
por: Elenga, N, et al.
Publicado: (2022) -
Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients
por: Elenga, Narcisse, et al.
Publicado: (2022) -
PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
por: Yassin, Mohamed, et al.
Publicado: (2023) -
Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015) -
Selenium Status and Hemolysis in Sickle Cell Disease Patients
por: Delesderrier, Emília, et al.
Publicado: (2019)